Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Am J Health Syst Pharm. 2016 Dec 1;73(23):1986–1998. doi: 10.2146/ajhp160104

Table 3.

Challenges to Incorporating Pharmacogenomics Education into Pharmacy Curricula

Challenges Potential Solutions
Lack of faculty with practice and teaching expertise in pharmacogenomics
  • Shared curricula and/or teaching resources

  • Train-the-trainer programs for educators

  • Collaboration with existing resources (e.g., G2C2, G3C) to increase awareness and use of these resources among pharmacy educators

Limited depth and breadth of instruction
  • Coverage of domains such as genomic basis of disease, bioinformatics, proteomics, metabolomics, genetic testing processes, and ethical, social, and economic implications is often limited.

  • Limited fidelity of instruction (understanding testing process or providing pharmacogenomics communication first-hand)

  • Limited space within most curricula to incorporate new topics

  • Development of early foundational education in pharmacogenomics and related “omics” topics for pharmacy and undergraduate students

  • Working with real data and/or an optional opportunity for learners to personally undergo genetic testing to experience process.

  • Development of resources to enable educators to weave pharmacogenomics into existing pharmacotherapy coursework (e.g., teaching cases)

  • Incorporation of non-patient care elements (e.g., test ordering and evaluation, ethical issues, bioinformatics, communication of results) into pharmacogenomics patient cases to allow synergy in teaching these topics

Varying degrees of clinical implementation
  • May affect clinical faculty expertise and hamper delivery of pharmacogenomics-based experiential education (i.e., IPPEs, APPEs).

  • Preceptors/faculty are challenged in staying current with clinical pharmacogenomics applications and emerging literature.

  • Teaching implementation science in conjunction with pharmacogenomics education aimed at knowledge attainment and its application when local implementation programs are not yet available.

  • Disseminating practice models in which students and trainees actively participate in clinical implementations to support further development of these practices

  • Establishment of practitioner/faculty-focused mechanisms to increase communication, collaboration, and awareness of practice and learning activities and emerging literature (e.g., discussion board, listserv)

  • Development of an online journal club to discuss key emerging literature and its clinical relevance

Variable needs and opportunities for practitioner education
  • Requisite knowledge and skills may differ based on practice setting

  • Limited post-Pharm.D. residency and fellowship opportunities.

  • Residency program collaboration to increase awareness of opportunities for and content of post-graduate training (e.g., residency)

  • Development and dissemination of resources (e.g., sample syllabi, learning activities, assignments) to support creation of an elective pharmacogenomics rotation for APPE students and PGY1 residents

  • Development of national preceptor training programs for teaching pharmacogenomics competencies